340B Purchases To Hit 8% Of Outpatient Brand Drug Sales In 2019 – White Paper
This article was originally published in The Pink Sheet Daily
Berkeley Research Group finds fault with the oft-cited idea that 340B accounts for only 2% of total drug sales. Meanwhile, 340B hospitals issue their own data showing they serve lower-income populations than other hospitals.
Register for our free email digests: